July 1, 2012
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return — it's a question of when. And for far too many, it happens far too soon.
June 25, 2012
Cancer medicine must depart from a one-size-fits-all tradition, and move instead to targeted treatments, said cancer expert Frank McCormick, PhD, FRS, during a congressional forum this week that focused on cutting-edge cancer research and treatment.
June 20, 2012
Liver cancer is expected to become more common in the United States in coming years. “It’s deadly and it’s preventable,” says UCSF physician and researcher Tung Nguyen, MD.
June 14, 2012
A new approach to drug design, pioneered by a group of researchers at the University of California, San Francisco (UCSF) and Mt. Sinai, New York, promises to help identify future drugs to fight cancer and other diseases that will be more effective and have fewer side effects.
June 12, 2012
Concern about overexposure to radiation due to excessive use of medical imaging has come to the fore in recent years. Now, a study led by researchers at the University of California, San Francisco (UCSF) and Group Health Research Institute, shows that medical imaging is increasing even in health maintenance organization systems (HMOs), which don’t have a financial incentive to conduct them.
June 11, 2012
A report issued by the Institute of Medicine (IOM) last December reviewed all the available scientific data compiled to date about potential environmental risks of breast cancer—factors such as pesticides, beauty products, household chemicals, and the plastics used to make water bottles.
June 4, 2012
A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients receiving the placebo to instead take the drug because of the favorable results.
June 1, 2012
Cancer drug development is known to be too slow, costly and fraught with failure. Now the U.S. Food and Drug Administration is issuing recommendations for breast cancer trials that would substantially accelerate patient access to new medications while lowering the time and cost of drug development.
May 30, 2012
At one of the highest-ranked medical schools in the country, it’s not surprising to find students with big appetites for learning. In the laboratory, there are those who seek out challenges at the bench, peering into microscopes for answers.
May 4, 2012
It’s a real challenge to treat a patient with relapsed cancer, because the cancer has outsmarted initial treatment and has become more resistant, says Steven DuBois, MD, assistant professor of pediatrics at UCSF’s School of Medicine and a specialist in childhood cancers.